TIF
An educational leaflet aiming to strengthen the knowledge and understanding of patients with thalassaemia and other haemoglobin disorders across the world on most aspects relevant to gene therapy.
Latest News:
- Cypriot Stella Kyriakides named EU Health Commissioner
- TIF issues new leaflet on gene therapy for patients with β-thalassaemia and other haemoglobin disorders
- Biotech companies issue first joint declaration on human gene editing
- Deferasirox Mylan: A new generic drug for the treatment of iron overload in β-thalassaemia major pending approval by the EMA
- World Patient Safety Day – 17 September 2019
